NCT06031142

Brief Summary

The goal of this observational is to compare in describing fetal health conditions. The main questions it aims to answer are:

  • fetal electrocardiogram (fetal heart rate and fetal rhythm)
  • electrohysterography (uterine contractions). Participants will wear wearable devices and CTG equipment for monitoring for 30 minutes.If there is a comparison group: Researchers will compare clinical CTG equipment to see if this wearable device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2023

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

August 29, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
Last Updated

September 11, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

August 29, 2023

Last Update Submit

September 3, 2023

Conditions

Keywords

FECGEHG

Outcome Measures

Primary Outcomes (2)

  • The performance of this system in extracting fetal electrocardiogram (FECG)

    extract fetal QRS intervals and numbers from FECG

    2022.01-2023.08

  • The performance of this system in extracting electrohysterography (EHG)

    use the contractions consistency index (CCI) parameters to analyze the relation between our measured EHG signal and the UC signal recorded by clinical CTG equipment.

    2022.01-2023.08

Interventions

We used wearable devices and clinical cardiotocography (CTG) equipment to monitor pregnant women for 30 minutes to demonstrate the reliability of wearable devices.

Also known as: Non-invasive monitoring, FECG, EHG

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A wearable and remote fetal monitoring system is specifically developed for home use. It aims to overcome the limitations of conventional cardiotocography (CTG) devices by providing great user comfort and long-term continuous monitoring.

You may qualify if:

  • Pregnant women with a gestational cycle greater than 36 weeks

You may not qualify if:

  • male
  • Pregnant women with a gestational cycle less than 36 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FetaCare

Shanghai, Pudong New District, Shanghai, 200100, China

Location

MeSH Terms

Conditions

Homing Behavior

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Study Officials

  • Tingting Li, master

    Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 11, 2023

Study Start

May 29, 2023

Primary Completion

July 29, 2023

Study Completion

August 6, 2023

Last Updated

September 11, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations